(Q52680155)

English

Randomized, controlled, double-blind trial with ivermectin on Loa loa microfilaraemia: efficacy of a low dose (approximately 25 microg/kg) versus current standard dose (150 microg/kg).

scientific article published on 24 May 2007

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

5 May 2018

http://europepmc.org/abstract/MED/17531279

Randomized, controlled, double-blind trial with ivermectin on Loa loa microfilaraemia: efficacy of a low dose (approximately 25 microg/kg) versus current standard dose (150 microg/kg). (English)

1 reference

Europe PubMed Central

5 May 2018

http://europepmc.org/abstract/MED/17531279

0 references

object named as

Loa loa

1 reference

based on heuristic

inferred from title

1

object named as

Joseph Kamgno

1 reference

Europe PubMed Central

5 May 2018

http://europepmc.org/abstract/MED/17531279

Michel Boussinesq

6

object named as

Michel Boussinesq

1 reference

Europe PubMed Central

5 May 2018

http://europepmc.org/abstract/MED/17531279

author name string

Sébastien D S Pion

2

1 reference

Europe PubMed Central

5 May 2018

http://europepmc.org/abstract/MED/17531279

Mathurin C Tejiokem

3

1 reference

Europe PubMed Central

5 May 2018

http://europepmc.org/abstract/MED/17531279

Nana A Y Twum-Danso

4

1 reference

Europe PubMed Central

5 May 2018

http://europepmc.org/abstract/MED/17531279

Björn Thylefors

5

1 reference

Europe PubMed Central

5 May 2018

http://europepmc.org/abstract/MED/17531279

publication date

24 May 2007

1 reference

Europe PubMed Central

5 May 2018

http://europepmc.org/abstract/MED/17531279

number of pages

9

1 reference

based on heuristic

inferred from page(s)

Transactions of the Royal Society of Tropical Medicine and Hygiene

1 reference

Europe PubMed Central

5 May 2018

http://europepmc.org/abstract/MED/17531279

101

1 reference

Europe PubMed Central

5 May 2018

http://europepmc.org/abstract/MED/17531279

8

1 reference

Europe PubMed Central

5 May 2018

http://europepmc.org/abstract/MED/17531279

777-785

1 reference

Europe PubMed Central

5 May 2018

http://europepmc.org/abstract/MED/17531279

Immunocompetence may be important in the effectiveness of Mectizan (ivermectin) in the treatment of human onchocerciasis

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2007.03.018

7 January 2021

Clinical picture, epidemiology and outcome of Loa-associated serious adverse events related to mass ivermectin treatment of onchocerciasis in Cameroon

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2007.03.018

7 January 2021

Obligatory symbiotic Wolbachia endobacteria are absent from Loa loa

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2007.03.018

7 January 2021

Ocular findings after ivermectin treatment of patients with high Loa loa microfilaremia

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2007.03.018

7 January 2021

Serious reactions after mass treatment of onchocerciasis with ivermectin in an area endemic for Loa loa infection.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2007.03.018

7 January 2021

The effect of antimalarial chloroquine therapy and prophylaxis on concurrent infection with Onchocerca volvulus in Ecuador

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2007.03.018

7 January 2021

Programmatic and Communication Issues in Relation to Serious Adverse Events Following Ivermectin Treatment in areas Co-endemic for Onchocerciasis and Loiasis

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2007.03.018

7 January 2021

Effect of a single dose (600 mg) of albendazole on Loa loa microfilaraemia

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2007.03.018

7 January 2021

Bacterial endosymbionts of Onchocerca volvulus in the pathogenesis of posttreatment reactions

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2007.03.018

7 January 2021

Albendazole in human loiasis: results of a double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2007.03.018

7 January 2021

Evidence against Wolbachia symbiosis in Loa loa

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2007.03.018

7 January 2021

C-reactive protein and interleukin-6 are elevated in onchocerciasis patients after ivermectin treatment.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2007.03.018

7 January 2021

Prospects for elimination of bancroftian filariasis by mass drug treatment in Pondicherry, India: a simulation study

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2007.03.018

7 January 2021

Effects of a 3-day regimen of albendazole (800 mg daily) on Loa loa microfilaraemia

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2007.03.018

7 January 2021

Variation in incidence of serious adverse events after onchocerciasis treatment with ivermectin in areas of Cameroon co-endemic for loiasis

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2007.03.018

7 January 2021

Ivermectin in loiasis and concomitant O. volvulus and M. perstans infections

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2007.03.018

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.TRSTMH.2007.03.018

1 reference

Europe PubMed Central

5 May 2018

http://europepmc.org/abstract/MED/17531279

1 reference

Europe PubMed Central

5 May 2018

http://europepmc.org/abstract/MED/17531279

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q52680155&oldid=1864578324"